drugset / Trial / NCT01355614
A Phase II Efficacy Study in Fistulizing Crohn's Disease Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will assess the safety and efficacy of QAX576 if patients with fistulizing Crohn's disease.
Timeline
- Start
- 2011-06
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Infliximab | Monoclonal antibody | — | — |
| Subject | QAX576 | Monoclonal antibody | — | — |